Annual Shareholders Equity
$119.80 M
-$31.21 M-20.67%
December 31, 2023
Summary
- As of February 7, 2025, ALDX annual stockholders equity is $119.80 million, with the most recent change of -$31.21 million (-20.67%) on December 31, 2023.
- During the last 3 years, ALDX annual shareholders equity has risen by +$60.29 million (+101.31%).
- ALDX annual shareholders equity is now -41.77% below its all-time high of $205.74 million, reached on December 31, 2021.
Performance
ALDX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$85.10 M
-$13.21 M-13.44%
September 30, 2024
Summary
- As of February 7, 2025, ALDX quarterly stockholders equity is $85.10 million, with the most recent change of -$13.21 million (-13.44%) on September 30, 2024.
- Over the past year, ALDX quarterly shareholders equity has dropped by -$37.91 million (-30.82%).
- ALDX quarterly shareholders equity is now -63.58% below its all-time high of $233.68 million, reached on June 30, 2021.
Performance
ALDX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ALDX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.7% | -30.8% |
| 3 y3 years | +101.3% | -61.3% |
| 5 y5 years | +38.3% | +67.3% |
ALDX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.8% | at low | -58.6% | at low |
| 5 y | 5-year | -41.8% | +149.2% | -63.6% | +95.8% |
| alltime | all time | -41.8% | +576.2% | -63.6% | +438.3% |
Aldeyra Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $85.10 M(-13.4%) |
| Jun 2024 | - | $98.31 M(-13.3%) |
| Mar 2024 | - | $113.42 M(-5.3%) |
| Dec 2023 | $119.80 M(-20.7%) | $119.80 M(-2.6%) |
| Sep 2023 | - | $123.01 M(-5.3%) |
| Jun 2023 | - | $129.88 M(-5.4%) |
| Mar 2023 | - | $137.24 M(-9.1%) |
| Dec 2022 | $151.01 M(-26.6%) | $151.01 M(-6.9%) |
| Sep 2022 | - | $162.19 M(-6.8%) |
| Jun 2022 | - | $174.03 M(-8.7%) |
| Mar 2022 | - | $190.69 M(-7.3%) |
| Dec 2021 | $205.74 M(+245.7%) | $205.74 M(-6.3%) |
| Sep 2021 | - | $219.67 M(-6.0%) |
| Jun 2021 | - | $233.68 M(+85.4%) |
| Mar 2021 | - | $126.07 M(+111.9%) |
| Dec 2020 | $59.51 M(+23.8%) | $59.51 M(-14.0%) |
| Sep 2020 | - | $69.17 M(+31.0%) |
| Jun 2020 | - | $52.79 M(+21.4%) |
| Mar 2020 | - | $43.47 M(-9.6%) |
| Dec 2019 | $48.08 M(-44.5%) | $48.08 M(-5.5%) |
| Sep 2019 | - | $50.88 M(-24.4%) |
| Jun 2019 | - | $67.33 M(-14.2%) |
| Mar 2019 | - | $78.48 M(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $86.62 M(+118.7%) | $86.62 M(+202.9%) |
| Sep 2018 | - | $28.60 M(-22.7%) |
| Jun 2018 | - | $36.98 M(+2.7%) |
| Mar 2018 | - | $36.00 M(-9.1%) |
| Dec 2017 | $39.60 M(+82.9%) | $39.60 M(-13.7%) |
| Sep 2017 | - | $45.90 M(+96.7%) |
| Jun 2017 | - | $23.34 M(-16.6%) |
| Mar 2017 | - | $28.00 M(+29.3%) |
| Dec 2016 | $21.65 M(-13.0%) | $21.65 M(-15.7%) |
| Sep 2016 | - | $25.67 M(-13.0%) |
| Jun 2016 | - | $29.52 M(+43.8%) |
| Mar 2016 | - | $20.53 M(-17.5%) |
| Dec 2015 | $24.88 M(+295.9%) | $24.88 M(-13.3%) |
| Sep 2015 | - | $28.70 M(-9.0%) |
| Jun 2015 | - | $31.52 M(+128.0%) |
| Mar 2015 | - | $13.83 M(+120.0%) |
| Dec 2014 | $6.28 M(-430.0%) | $6.28 M(-24.0%) |
| Sep 2014 | - | $8.26 M(-15.8%) |
| Jun 2014 | - | $9.81 M(-963.5%) |
| Mar 2014 | - | -$1.14 M(-40.3%) |
| Dec 2013 | -$1.90 M(-92.4%) | -$1.90 M(-83.8%) |
| Sep 2013 | - | -$11.76 M(-53.2%) |
| Dec 2012 | -$25.15 M(+977.5%) | -$25.15 M |
| Dec 2011 | -$2.33 M | - |
FAQ
- What is Aldeyra Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual shareholders equity year-on-year change?
- What is Aldeyra Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly shareholders equity year-on-year change?
What is Aldeyra Therapeutics annual stockholders equity?
The current annual shareholders equity of ALDX is $119.80 M
What is the all time high annual shareholders equity for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual stockholders equity is $205.74 M
What is Aldeyra Therapeutics annual shareholders equity year-on-year change?
Over the past year, ALDX annual stockholders equity has changed by -$31.21 M (-20.67%)
What is Aldeyra Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ALDX is $85.10 M
What is the all time high quarterly shareholders equity for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly stockholders equity is $233.68 M
What is Aldeyra Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ALDX quarterly stockholders equity has changed by -$37.91 M (-30.82%)